
FDA Approves New Blood Thinner to Cut Repeat Strokes by 26%
The FDA has approved Sunharbo, the first drug to block clotting protein Factor XIa — a once-daily pill that cut repeat strokes by 26% in a major trial.
By: hammadkhaksar2 articles found under this topic

The FDA has approved Sunharbo, the first drug to block clotting protein Factor XIa — a once-daily pill that cut repeat strokes by 26% in a major trial.
By: hammadkhaksar
The US Food and Drug Administration has ordered new warnings about a rare risk of sudden vision loss on popular weight-loss and diabetes drugs including Ozempic and Zepbound.
By: hammadkhaksar